Text Version
Entrez PubMed Overview Help | FAQ Tutorial New/Noteworthy E-Utilities
PubMed Services Journals Database MeSH Database Single Citation Matcher Batch Citation Matcher Clinical Queries LinkOut Cubby
Related Resources Order Documents NLM
Gateway TOXNET Consumer
Health Clinical Alerts ClinicalTrials.gov PubMed
Central
Privacy Policy
|
|
-
SSRI-associated nocturnal bruxism
in four patients.
Ellison JM, Stanziani
P.
Department of Psychiatry, Tufts/New England Medical
Center, Boston, Mass. 02111.
BACKGROUND: Nocturnal bruxism (tooth
clenching and/or grinding during sleep) affects a significant proportion
of the population. Its etiology remains uncertain, and no entirely
satisfactory treatment is available. METHOD: This is an observational
report of four depressed individuals selected from one psychiatrist's
practice within an urban hospital's psychopharmacology clinic.
Psychiatric diagnoses were made according to DSM-III-R criteria.
Nocturnal bruxism was determined on the basis of dental examination
and/or self-reported nocturnal tooth clenching and/or grinding. RESULTS:
Four patients developed nocturnal bruxism within 2 to 4 weeks after
initiation of treatment with fluoxetine or sertraline. Bruxism remitted
in all patients after a decrease in antidepressant dosage (N = 1) or
addition of buspirone (N = 3). CONCLUSION: These observations, which
should be confirmed by a controlled study, suggest an association
between serotonin selective reuptake inhibitor (SSRI) treatment and the
onset or exacerbation of nocturnal bruxism. In addition, they suggest
that a decrease in SSRI dosage or the addition of buspirone may relieve
SSRI-associated nocturnal bruxism.
Publication Types:
PMID: 8270587 [PubMed - indexed for
MEDLINE]
|